Picture of Immunovia AB (publ) logo

IMMNOV Immunovia AB (publ) News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Immunovia's usTest To Be Part Of U.S. Pancreatic Cysts Study

Aug 5 (Reuters) - Immunovia AB (publ)  IMMNOV.ST :
    * IMMUNOVIA'S NEXT GENERATION TEST TO BE INCLUDED IN LARGE
STUDY
OF PANCREATIC CYSTS FUNDED BY U.S. NATIONAL INSTITUTES OF HEALTH
    * IS ON TRACK TO LAUNCH NEW TEST IN UNITED STATES IN 2025
    * FIRST U.S. STUDY SHOULD BE COMPLETED IN 2025; OTHER TWO
WILL
LAST APPROXIMATELY FIVE YEARS

Source text for Eikon:  ID:nWkr8fSNmK 
Further company coverage:  IMMNOV.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on Immunovia AB (publ)

See all news